Patients with low risk prostate cancer on active surveillance experience good quality of life

Active surveillance (AS) has become an increasingly important alternative to surgery, chemotherapy, or radiation treatment for men diagnosed with low risk prostate cancer. However, what is the impact of AS on health-related quality of life (HRQoL) in patients selected or opting for this conservative form of disease management? New research found that patients on AS who were tracked for three years experienced similar HRQoL as men without prostate cancer, both clinically and psychologically.